EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
2 hedge funds and large institutions have $12.1K invested in Eagle Pharmaceuticals, Inc. in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-7
Holders Change %
-77.78%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SLG
1
Stanley-Laman Group
Berwyn,
Pennsylvania
| $11.8K | – | – | – |
|
|
AIC
2
Archer Investment Corporation
Carmel,
Indiana
| $343 | – | – | – |
|
|
XT
3
XTX Topco
George Town,
Cayman Islands
| – | -$11.8K | -23,594 | Closed |
|
4
Simplex Trading
Chicago,
Illinois
| – | -$9K | -18,162 | Closed |
|
5
Barclays
London,
United Kingdom
| – | -$7K | -14,233 | Closed |
|
6
Acadian Asset Management
Boston,
Massachusetts
| – | -$3K | -7,155 | Closed |
|
7
Russell Investments Group
London,
United Kingdom
| – | -$1.71K | -3,411 | Closed |
|
8
Credit Agricole
Montrouge Cedex,
France
| – | -$18 | -36 | Closed |
|
|
FFA
9
Farther Finance Advisors
San Francisco,
California
| – | -$18 | -35 | Closed |
|